#62024CJ0601EU Court clarifies import rules for Japanese seahorse products
AI-generated summary for informational purposes only. Not legal advice. See the original source for the authoritative text.
Products made from protected wildlife can count as regulated “specimens” under EU wildlife trade rules, even when they are processed into tablets or extracts. The case concerns tablets containing Japanese seahorse extract brought into the EU without an import permit. The ruling matters for travellers, importers, customs authorities, and retailers dealing with traditional medicines, supplements, or other products made from protected species. Personal-use claims do not automatically remove the need for import controls, and Member States may apply criminal sanctions when protected wildlife products enter the EU without the required permit.
AI-generated summary. May contain errors. Refer to official sources for legal decisions.
Key Changes
- Clarifies that processed products containing protected species can still be treated as regulated wildlife specimens.
- Confirms that import permits may be required for products such as tablets containing Japanese seahorse extract.
- Supports enforcement, including criminal sanctions, for bringing protected wildlife products into the EU without the required permit.
Obligations
What this law requires
EU wildlife trade rules treat products made from protected species, including processed tablets or extracts containing Japanese seahorse, as regulated “specimens” where they fall within Regulation (EC) No 338/97.
Importing regulated specimens of protected wildlife into the European Union requires an import permit under Article 4(2) of Regulation (EC) No 338/97; personal-use claims do not automatically remove that requirement.
Member States may impose criminal sanctions under Article 16 of Regulation (EC) No 338/97 for introducing protected wildlife specimens into the European Union without the required import permit.